A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision

Indian Journal of Ophthalmology

Volumn 59, Issue 2, 2011, Pages 93-96

  Lim, Ji Won ^a   Na, Kyeong Ik ^a  

^a Hallym University   (South Korea)

Author keywords

Bevacizumab; central retinal vein occlusion; macular edema; triamcinolone

Indexed keywords

BEVACIZUMAB; GLUCOCORTICOID; MONOCLONAL ANTIBODY; TRIAMCINOLONE;

AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SPECTACLES; VISUAL ACUITY; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; EYEGLASSES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE; VISION DISORDERS; VISUAL ACUITY;

EID: 79952434731     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.77008     Document Type: Article

References (15)

1. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102:1434-44.
2. Evaluation of grid patern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-33.
3. Ip MS, Scot IU, Van Veldhuisen PC, Oden NL, Blodi BA, Fisher M, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-14.
4. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular oedema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-9. (Pubitemid 35034350)
5. Ip MS, Gotlieb JL, Kahana A, Scot IU, Altaweel MM, Blodi BA, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-6. (Pubitemid 39031127)
6. Goff MJ, Jumper JM, Yang SS, Fu AD, Johnson RN, McDonald HR, et al. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 2006;26:896-901. (Pubitemid 44547442)
7. Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: Six-month results of a prospective trial. Retina 2007;27:1004-12. (Pubitemid 350303999)
8. Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007;144:864-71. (Pubitemid 350122344)
9. Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, et al. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina 2007;27:1013-9. (Pubitemid 350304000)
10. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol 2004;49:470-90. (Pubitemid 39504763)
11. Tao Y, Hou J, Jiang YR, Li XX, Jonas JB. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye (Lond) 2010;24:810-5.
12. Cheng KC, Wu WC, Lin CJ. Intravitreal triamcinolone acetonide for patients with macular oedema due to central retinal vein occlusion in Taiwan. Eye (Lond) 2009;23:849-57.
13. Guthoff R, Meigen T, Hennemann K, Schrader W. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to central retinal vein occlusion: A matched pairs analysis. Ophthalmologica 2010;224:126-32.
14. Wu WC, Cheng KC, Wu HJ. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Eye (Lond) 2009;23:2215-22.
15. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997;115:486-91.